Impact of the COVID-19 Pandemic on Patients Without COVID-19 With Acute Myocardial Infarction and Heart Failure.

Background Excess mortality from cardiovascular disease during the COVID-19 pandemic has been reported. The mechanism is unclear but may include delay or deferral of care, or differential treatment during hospitalization because of strains on hospital capacity. Methods and Results We used emergency department and inpatient data from a 12-hospital health system to examine changes in volume, patient age and comorbidities, treatment (right- and left-heart catheterization), and outcomes for patients with acute myocardial infarction (AMI) and heart failure (HF) during the COVID-19 pandemic compared with pre-COVID-19 (2018 and 2019), controlling for seasonal variation.

The Challenge of Chamber Stiffness Determination in Chronic Atrial Fibrillation vs. Normal Sinus Rhythm: Echocardiographic Prediction with Simultaneous Hemodynamic Validation.

Echocardiographic diastolic function (DF) assessment remains a challenge in atrial fibrillation (AF), because indexes such as E/A cannot be used and because chronic, rate controlled AF causes chamber remodeling. To determine if echocardiography can accurately characterize diastolic chamber properties we compared 15 chronic AF subjects to 15, age matched normal sinus rhythm (NSR) subjects using simultaneous echocardiography-cardiac catheterization (391 beats analyzed). Conventional DF parameters (DT, Epeak, AT, Edur, E-VTI, E/E') and validated, E-wave derived, kinematic modeling based chamber stiffness parameter (k), were compared.